Published in: First Personal Medical Congress
COI code: IPMCMED01_079
Paper Language: English
How to Download This Paper
For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.
Authors Human microbiome as a future approach to personalized medicineHanieh-sadat Ejtahed - Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Shirin Hasani-Ranjbar - Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Bagher Larijani - Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Abstract:Individuals have different responses to different therapeutic agents which is the major problem in clinical practice. Huge amounts of time and money have been invested in looking for the sources of these variabilities. Human microbiome, the bacterial ecosystem residing in every human body which contributes 100 times more genes than the human genome, may be the true source of various responses. Since studies have shown that dysbiosis which results in alterations in both structural and functional profiles of the human microbiota is major contributors to the pathogenesis of immune, infectious and metabolic disorders, modulation of microbiota could be effective in personalized medicine. The term gut pharmacomicrobiomics implies the effect of the gut microbiome on pharmacokinetic and pharmacodynamic processes through the secretion of drug structure-modifying enzymes, secretion of metabolits interfering with drug metabolism, modification of intestinal and liver enzymes, and modulation of human metabolic genes expression. We can imagine a future that routinely analyzing the microbiome allows us to predict individualized responses to different foods and drugs. Microbiome analyzing of individuals may be added to future routine personalized medicine protocols after comparing the costs and benefits of this technology. Improved understanding of the human microbiome could lead to the development of novel therapeutic strategies for different diseases. Potential therapeutic agents such as personalized probiotic and prebiotic supplements, dietary interventions and fecal microbiota transplantation that can be used to reshape the gut microbiome represent a reasonable strategy to enter the era of personalized medicine.
Keywords:Gut microbiome, pharmacomicrobiomics, personalized medicine
COI code: IPMCMED01_079
how to cite to this paper:If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Ejtahed, Hanieh-sadat; Shirin Hasani-Ranjbar & Bagher Larijani, 2016, Human microbiome as a future approach to personalized medicine, First Personal Medical Congress, تهران, دانشگاه علوم پزشكي ايران - پژوهشكده ملي مهندسي ژنتيك و زيست فناوري ايران، مركز همكاري هاي فناوري و نوآوري هاي رياست جمهوري, https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_079.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Ejtahed, Hanieh-sadat; Shirin Hasani-Ranjbar & Bagher Larijani, 2016)
Second and more: (Ejtahed; Hasani-Ranjbar & Larijani, 2016)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)
The University/Research Center Information:
Type: Medical University
Paper No.: 6375
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.
Research Info Management
Export Citation info of this paper to research management softwares
New Related Papers
- Breastfeeding in Disasters: A Reminder for Policymakers
- The Most Common Tools to Measure Trauma Severity: A review Study
- Hospital Safety Index in Hospitals Affiliated with Alborz University of Medical Sciences in 2015
- Providing Business Continuity Plan after Natural Disasters: A Case Study in the Staff Area of Water and Wastewater Company of Tehran
- The Effect of Climatic Change on the Current and Future Niche of Zoonotic Cutaneous Leishmaniasis Vector and Reservoir Species in Yazd Province
The Above articles are recently indexed in the related subjects
Iran Scientific Advertisment Netword
Share this paper
WHAT IS COI?
COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.